Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations
Huntsman Cancer Institute at the University of Utah
For Immediate Release
SALT LAKE CITY ― Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).
“This joint statement from the nation’s top cancer centers recognizes low rates of HPV vaccination as a serious public health issue,” says Mary Beckerle, PhD, CEO and Director of HCI. “We are excited to collaborate with our peers to advocate for widespread HPV vaccination in our community.”
According to the CDC, incidence rates of HPV-associated cancers have continued to rise, with approximately 39,000 new HPV-associated cancers now diagnosed each year in the United States. Although HPV vaccines can prevent the majority of cervical, anal, oropharyngeal (middle throat), and other genital cancers, vaccination rates remain low across the U.S., with just 41.9 percent of girls and 28.1 percent of boys completing the recommended vaccine series.
“Utah is unique because we have one of the lowest HPV vaccination rates in the U.S.,” says Deanna Kepka, PhD, MPH, and HCI investigator. “This is often due to a lack of strong recommendations from providers, and parents not understanding that this vaccine protects against several types of cancer.”
Since 2014 Kepka has led the Intermountain West HPV Vaccination Coalition, which brings together immunization program representatives with cancer control, pediatric, and primary care specialists as well as parents and community members who share the common goal of improving HPV vaccination rates. There are currently more than 300 coalition members from different states across the western U.S., including Arizona, Colorado, Idaho, Montana, New Mexico, Nevada, Oregon, Utah, Washington, and Wyoming.
“HPV vaccination is cancer prevention,” says Kepka. “It is our best defense in stopping HPV infection in our youth and preventing HPV-related cancers in our communities. We ask health care providers to join forces to educate parents, guardians, and colleagues about the importance and benefits of HPV vaccination.”
The new guidelines from the CDC recommend that children aged 11 to 12 should receive two doses of the HPV vaccine at least six months apart. Adolescents and young adults older than 15 should continue to complete the three-dose series.
“We have been inspired by the White House Cancer Moonshot to work together in eliminating cancer,” says Electra Paskett, PhD, co-leader of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) Cancer Control Research Program. “Improving HPV vaccination is an example of an evidence-based prevention strategy we can implement today to save thousands of lives in the future.”
The NCI-designated cancer centers’ joint statement is the result of discussions from the most recent summit, hosted this summer by The Ohio State University Comprehensive Cancer Center. Nearly 150 experts from across the country gathered in Columbus to present research updates and plan future collaborative actions across NCI-designated cancer centers.
Public Relations - Huntsman Cancer Institute
About Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute (HCI) is one of the world’s top academic research and cancer treatment centers. HCI manages the Utah Population Database - the largest genetic database in the world, with more than 16 million records linked to genealogies, health records, and vital statistics. Using this data, HCI researchers have identified several cancer-causing genes, including the genes responsible for melanoma, colon and breast cancer, and paraganglioma. HCI is a member of the National Comprehensive Cancer Network (a 27-member alliance of the world's leading cancer centers) and is a National Cancer Institute-Designated Comprehensive Cancer Center. HCI treats patients with all forms of cancer and operates several high-risk clinics that focus on melanoma and breast, colon, and pancreas cancers. The HCI Cancer Learning Center for patient and public education contains one of the nation's largest collections of cancer-related publications. The institute is named after Jon M. Huntsman, a Utah philanthropist, industrialist, and cancer survivor.